147 related articles for article (PubMed ID: 16787351)
1. Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines.
Fukuda N
Med Chem; 2006 Jan; 2(1):13-9. PubMed ID: 16787351
[TBL] [Abstract][Full Text] [Related]
2. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset.
Otsuki M; Fukuda N; Inoue T; Mineshige T; Otsuki T; Horikoshi S; Endo M; Abe M
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480595
[TBL] [Abstract][Full Text] [Related]
4. A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery.
Yao EH; Fukuda N; Ueno T; Matsuda H; Nagase H; Matsumoto Y; Sugiyama H; Matsumoto K
Cardiovasc Res; 2009 Mar; 81(4):797-804. PubMed ID: 19098300
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
Matsuda H; Fukuda N; Ueno T; Katakawa M; Wang X; Watanabe T; Matsui S; Aoyama T; Saito K; Bando T; Matsumoto Y; Nagase H; Matsumoto K; Sugiyama H
Kidney Int; 2011 Jan; 79(1):46-56. PubMed ID: 20861821
[TBL] [Abstract][Full Text] [Related]
6. Contribution of TGF-β1 and Effects of Gene Silencer Pyrrole-Imidazole Polyamides Targeting TGF-β1 in Diabetic Nephropathy.
Horikoshi S; Fukuda N; Tsunemi A; Okamura M; Otsuki M; Endo M; Abe M
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093382
[TBL] [Abstract][Full Text] [Related]
7. RNA binding properties of novel gene silencing pyrrole-imidazole polyamides.
Iguchi A; Fukuda N; Takahashi T; Watanabe T; Matsuda H; Nagase H; Bando T; Sugiyama H; Shimizu K
Biol Pharm Bull; 2013; 36(7):1152-8. PubMed ID: 23628892
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel gene silencer pyrrole-imidazole polyamide targeting human connective tissue growth factor.
Wan JX; Fukuda N; Ueno T; Watanabe T; Matsuda H; Saito K; Nagase H; Matsumoto Y; Matsumoto K
Biol Pharm Bull; 2011; 34(10):1572-7. PubMed ID: 21963497
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional inhibition of hypertrophic scars by a gene silencer, pyrrole-imidazole polyamide, targeting the TGF-β1 promoter.
Washio H; Fukuda N; Matsuda H; Nagase H; Watanabe T; Matsumoto Y; Terui T
J Invest Dermatol; 2011 Oct; 131(10):1987-95. PubMed ID: 21654833
[TBL] [Abstract][Full Text] [Related]
10. Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene.
Lai YM; Fukuda N; Ueno T; Matsuda H; Saito S; Matsumoto K; Ayame H; Bando T; Sugiyama H; Mugishima H; Serie K
J Pharmacol Exp Ther; 2005 Nov; 315(2):571-5. PubMed ID: 16120815
[TBL] [Abstract][Full Text] [Related]
11. Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury.
Kotani M; Fukuda N; Ando H; Hu WY; Kunimoto S; Saito S; Kanmatsuse K
Cardiovasc Res; 2003 Jan; 57(1):265-76. PubMed ID: 12504837
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Study of Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Hypertrophic Scars in a Common Marmoset Primate Model.
Igarashi J; Fukuda N; Inoue T; Nakai S; Saito K; Fujiwara K; Matsuda H; Ueno T; Matsumoto Y; Watanabe T; Nagase H; Bando T; Sugiyama H; Itoh T; Soma M
PLoS One; 2015; 10(5):e0125295. PubMed ID: 25938472
[TBL] [Abstract][Full Text] [Related]
13. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury.
Ando H; Fukuda N; Kotani M; Yokoyama Si; Kunimoto S; Matsumoto K; Saito S; Kanmatsuse K; Mugishima H
Eur J Pharmacol; 2004 Jan; 483(2-3):207-14. PubMed ID: 14729108
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta as a treatment target in renal diseases.
Fukuda N; Tahira Y; Matsuda H; Matsumoto K
J Nephrol; 2009; 22(6):708-15. PubMed ID: 19967649
[TBL] [Abstract][Full Text] [Related]
15. Development of multifunctional pyrrole-imidazole polyamides that increase hepatocyte growth factor and suppress transforming growth factor-β1.
Chen L; Fukuda N; Ueno T; Abe M; Matsumoto T
J Pharmacol Sci; 2024 Jan; 154(1):1-8. PubMed ID: 38081679
[TBL] [Abstract][Full Text] [Related]
16. Effects of antisense peptide nucleic acid to platelet-derived growth factor A-chain on growth of vascular smooth muscle cells.
Fukuda N; Furuya R; Kishioka H; Suzuki R; Matsuda H; Tahira Y; Takagi H; Ikeda Y; Saito S; Matsumoto K; Kanmatsuse K
J Cardiovasc Pharmacol; 2003 Aug; 42(2):224-31. PubMed ID: 12883326
[TBL] [Abstract][Full Text] [Related]
17. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures.
Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K
J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586
[TBL] [Abstract][Full Text] [Related]
19. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function.
Ueno T; Fukuda N; Tsunemi A; Yao EH; Matsuda H; Tahira K; Matsumoto T; Matsumoto K; Matsumoto Y; Nagase H; Sugiyama H; Sawamura T
J Hypertens; 2009 Mar; 27(3):508-16. PubMed ID: 19330905
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of human gingival fibroblasts by chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1.
Yusa J; Fukuda N; Sato S; Matsmoto K; Mugishima H; Kamoi K
J Periodontol; 2005 Aug; 76(8):1265-74. PubMed ID: 16101357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
